89-005-658
integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51), Mouse, Polyclonal Antibody, Abnova™
Manufacturer: Abnova Corporation
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 89-005-658-Each-of-1 | In Stock | ₹ 44,411.00 |
89-005-658 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,411.00
GST (18%): ₹ 7,993.98
Total Price: ₹ 52,404.98
Antigen
integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
Classification
Polyclonal
Description
Mouse polyclonal antibody raised against a full-length human ITGAV protein.
Gene
ITGAV
Gene Alias
CD51/DKFZp686A08142/MSK8/VNRA
Host Species
Mouse
Quantity
50 μL
Whole Molecule
Yes
Gene ID (Entrez)
3685
Content And Storage
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Applications
Western Blot
Conjugate
Unconjugated
Formulation
No additive
Gene Accession No.
NM_002210
Gene Symbols
ITGAV
Immunogen
ITGAV (NP_002201, 1 a.a. ∼ 1048 a.a) full-length human protein.
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Serum
Related Products
Description
- ITAGV encodes integrin alpha chain V
- Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain
- The I-domain containing integrin alpha V undergoes post-translational cleavage to yield disulfide-linked heavy and light chains, that combine with multiple integrin beta chains to form different integrins
- Among the known associating beta chains (beta chains 1,3,5,6, and 8; 'ITGB1', 'ITGB3', 'ITGB5', 'ITGB6', and 'ITGB8'), each can interact with extracellular matrix ligands; the alpha V beta 3 integrin, perhaps the most studied of these, is referred to as the Vitronectin receptor (VNR)
- In addition to adhesion, many integrins are known to facilitate signal transduction
- Alternative splicing results in multiple transcript variants
- [provided by RefSeq] Sequence: MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEYSGPEGSYFGFAVDFFVPSASSQMFLLVGAPKANTTQPGIVEGGQVLKCDWSSTRRCQPIEFDATGNRDYAKDDPLEFKSHQWFGASVRSKQDKILACAPLYHWRTEMKQEREPVGTCFLQDGTKTVEYAPCRSQDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQGQLISDQVAEIVSKYDPNVYSIKYNNQLATRTAQAIFDDSYLGYSVAVGDFNGDGIDDFVSGVPRAARTLGMVYIYDGKNMSSLYNFTGEQMAAYFGFSVAATDINGDDYADVFIGAPLFMDRGSDGKLQEVGQVSVSLQRASGDFQTTKLNGFEVFARFGSAIAPLGDLDQDGFNDIAIAAPYGGEDKKGIVYIFNGRSTGLNAVPSQILEGQWAARSMPPSFGYSMKGATDIDKNGYPDLIVGAFGVDRAILYRARPVITVNAGLEVYPSILNQDNKTCSLPGTALKVSCFNVRFCLKADGKGVLPRKLNFQVELLLDKLKQKGAIRRALFLYSRSPSHSKNMTISRGGLMQCEELIAYLRDESEFRDKLTPITIFMEYRLDYRTAADTTGLQPILNQFTPANISRQAHILLDCGEDNVCKPKLEVSVDSDQKKIYIGDDNPLTLIVKAQNQGEGAYEAELIVSIPLQADFIGVVRNNEALARLSCAFKTENQTRQVVCDLGNPMKAGTQLLAGLRFSVHQQSEMDTSVKFDLQIQSSNLFDKVSPVVSHKVDLAVLAAVEIRGVSSPDHIFLPIPNWEHKENPETEEDVGPVVQHIYELRNNGPSSFSKAMLHLQWPYKYNNNTLLYILHYDIDGPMNCTSDMEINPLRIKISSLQTTEKNDTVAGQGERDHLITKRDLALSEGDIHTLGCGVAQCLKIVCQVGRLDRGKSAILYVKSLLWTETFMNKENQNHSYSLKSSASFNVIEFPYKNLPIEDITNSTLVTTNVTWGIQPAPMPVPVWVIILAVLAGLLLLAVLVFVMYRMGFFKRVRPPQEEQEREQLQPHENGEGNSET